Spatial analysis of CD8+ T cell neighbors using multiplexed immunofluorescence (MxIF) in esophageal squamous cell carcinoma (ESCC).
Abstract
e16100 Background: Little is known of how the spatial orientation of the tumor immune microenvironment (TIME) contributes to ESCC progression. Higher CD8+ T cell number correlates with improved response to immunotherapy and better survival. However, which cell types are close to CD8+ T cells at different stages or differentiation status of ESCC is unknown. We used MxIF to identify the location of CD8+ T cell neighbors (fibroblasts, epithelial cells, macrophages, eosinophils, CD4+ T cells, Tregs) and cell states (proliferation, apoptosis, DNA damage) to determine whether there are specific cell types neighboring CD8+ T cells associated with stage or differentiation. Methods: We created a tissue microarray of 27 ESCC resection specimens from Japanese patients who had no prior therapy and performed MxIF for the aforementioned cell types/states. We generated probability maps of positive markers in a substructure specific manner using machine learning to segment cells. Each cell was summed for marker combinations related to cell type/state for accurate distances between cells. Demographic characteristics were summarized using descriptive statistics. We calculated effective neighbor count by multiplying neighbor proportion of a cell type by cell type intensity to define the expected number of neighboring cells within 50 µm of each CD8+ T cell. Proportion is the number of CD8+ T cells with that cell type as a neighbor divided by the total number of CD8+ T cells (e.g. 55% of CD8+ T cells neighbor a macrophage). Intensity is the average number of neighbors per CD8+ T cell with 1 neighbor of that cell type (e.g. each CD8+ T cell with 1 macrophage neighbor had 20.5 macrophage neighbors, for an effective macrophage neighbor count of 11.3). Effective neighbor counts were compared across differentiation status, T- and N-stage using the Kruskal–Wallis or Wilcoxon rank-sum test, as appropriate. Results: Demographics are shown in the Table. The most effective neighbor cell types are macrophages (11.3), CD4+ T cells (9.3), and fibroblasts (6.0). In well versus poorly differentiated tumors, significantly more fibroblasts neighbor CD8+ T cells (p = 0.012), but fewer CD4+ T cells neighbor CD8+ T cells (p < 0.01). Stage T2/3 specimens exhibit more neighboring fibroblasts (p = 0.017) and fewer Treg neighbors (p = 0.064) to CD8+ T cells. There were no significant differences when comparing N0 vs N+. Conclusions: In these 27 patients with ESCC, CD8+ T cells more commonly neighbor fibroblasts in poorly differentiated and higher T-stage tumors. Future studies should focus on understanding the interaction of CD8+ T cell/fibroblast crosstalk during ESCC progression. Characteristic N = 27 Age (mean) 67 years Male Gender 67% Stage T1: 59%T2: 11%T3: 30% N-stage N0: 52%N+: 48% Differentiation Well: 22%Moderate: 59%Poor: 19% Tobacco use (mean) 33.7 pack years Alcohol use Social: 7%Habitual: 56%Heavy: 37%
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (10)
Margaret Wheless
Vanderbilt University Medical Center, Nashville, TN
Tatsuki Koyama
Department of Biostatistics, Vanderbilt University Medical Center, Nashville
Joseph Roland
Vanderbilt University Medical Center, Nashville, TN
Hajime Orita
Shinji Mine
Tsuyoshi Saito
Kazunari Yamashita
Juntendo University Hospital, Shizuoka, Japan
Michael K. Gibson
Vanderbilt-Ingram Cancer Center, Nashville, TN
Motomi Nasu
Department of Breast Oncology, Juntendo University Hospital, Bunkyo-Ku, Japan
Yash Choksi
Vanderbilt University Medical Center, Nashville, TN